Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gotham Enhanced 500 ETF
GSPY
|
+$160M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$31.8M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$15.4M |
| 4 |
DTE Energy
DTE
|
+$13.7M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$11.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$11.6M |
| 2 |
Public Service Enterprise Group
PEG
|
+$9.96M |
| 3 |
Automatic Data Processing
ADP
|
+$9.04M |
| 4 |
Eli Lilly
LLY
|
+$7.91M |
| 5 |
Pfizer
PFE
|
+$7.86M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.69% |
| 2 | Healthcare | 12.44% |
| 3 | Consumer Discretionary | 11.63% |
| 4 | Industrials | 11.59% |
| 5 | Financials | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Agilent Technologies
A
$44.9B
| $6.97M | 0.22% |
43,649
+13,290
| +44% | +$2.07M |
|
102
PepsiCo
PEP
$196B
| $6.97M | 0.22% |
40,100
-3,674
| -8% | -$600K |
|
103
Danaher
DHR
$154B
| $6.88M | 0.22% |
23,584
-1,759
| -7% | -$484K |
|
104
S&P Global
SPGI
$127B
| $6.82M | 0.22% |
14,449
+4,930
| +52% | +$2.26M |
|
105
NetApp
NTAP
$37.7B
| $6.57M | 0.21% |
71,421
+3,671
| +5% | +$331K |
|
106
Mastercard
MA
$509B
| $6.56M | 0.21% |
18,267
-175
| -0.9% | -$60.5K |
|
107
IBM
IBM
$222B
| $6.54M | 0.21% |
48,965
+727
| +2% | +$91.2K |
|
108
Dover
DOV
$27.2B
| $6.54M | 0.21% |
36,018
+13,862
| +63% | +$2.35M |
|
109
Constellation Brands
STZ
$23.2B
| $6.44M | 0.21% |
25,652
-7,689
| -23% | -$1.75M |
|
110
L3Harris
LHX
$49.7B
| $6.42M | 0.21% |
30,083
+23,362
| +348% | +$5.18M |
|
111
Thermo Fisher Scientific
TMO
$233B
| $6.37M | 0.21% |
9,544
+6,863
| +256% | +$4.28M |
|
112
Owens Corning
OC
$11.7B
| $6.37M | 0.21% |
70,337
+11,001
| +19% | +$999K |
|
113
CF Industries
CF
$19.6B
| $6.33M | 0.2% |
89,484
+30,687
| +52% | +$1.92M |
|
114
Dow Inc
DOW
$23.4B
| $6.25M | 0.2% |
110,228
+21,681
| +24% | +$1.24M |
|
115
Bristol-Myers Squibb
BMY
$137B
| $6.25M | 0.2% |
100,161
+5,381
| +6% | +$316K |
|
116
LKQ Corp
LKQ
$6.52B
| $6.24M | 0.2% |
103,882
-46,270
| -31% | -$2.61M |
|
117
Gilead Sciences
GILD
$181B
| $6.2M | 0.2% |
85,355
-31,662
| -27% | -$2.18M |
|
|
MRSH
118
Marsh
MRSH
$91.6B
| $6.12M | 0.2% |
35,225
+1,863
| +6% | +$309K |
|
119
Sherwin-Williams
SHW
$84.1B
| $6.09M | 0.2% |
17,308
-5,914
| -25% | -$1.91M |
|
120
International Paper
IP
$22B
| $6.08M | 0.2% |
129,435
+13,757
| +12% | +$678K |
|
121
Johnson Controls International
JCI
$86.7B
| $6.07M | 0.2% |
74,685
-28,099
| -27% | -$2.13M |
|
122
Intuit
INTU
$100B
| $5.99M | 0.19% |
9,319
-3,687
| -28% | -$2.28M |
|
123
Zebra Technologies
ZBRA
$17.4B
| $5.99M | 0.19% |
10,063
-3,897
| -28% | -$2.21M |
|
|
NLSN
124
DELISTED
Nielsen Holdings plc
NLSN
| $5.97M | 0.19% |
291,159
-182,666
| -39% | -$3.72M |
|
125
Freeport-McMoran
FCX
$110B
| $5.93M | 0.19% |
142,152
-49,648
| -26% | -$1.89M |
|
Similar funds
Joel Greenblatt's Q4 2021 Portfolio in Review
As of Q4 2021, Joel Greenblatt held 1,278 positions worth $3.1B, up 26% from $2.47B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Joel Greenblatt deployed $427M of net new capital in Q4 2021, opening 273 new positions and adding to 479 existing holdings. Its largest new stake was DTE Energy: 119,933 shares worth $14.3M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was DuPont de Nemours, an estimated $11.6M trimmed.
- Joel Greenblatt's largest Q4 2021 buy was DTE Energy: 119,933 shares worth $14.3M.
- Joel Greenblatt added most to Gotham Enhanced 500 ETF in Q4 2021, an estimated $160M increase.
- Joel Greenblatt's biggest Q4 2021 reduction was DuPont de Nemours, cutting an estimated $11.6M.
- Joel Greenblatt fully exited Carrier Global in Q4 2021, selling an estimated $3.93M.
- Joel Greenblatt's ten largest holdings make up 21% of its $3.1B portfolio in Q4 2021.
- Joel Greenblatt opened 273 new positions and closed 152 in Q4 2021.
- Joel Greenblatt's portfolio value rose 26% quarter-over-quarter to $3.1B.
Based on Gotham Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.